NCT00459537View on ClinicalTrials.gov

Efficacy, Safety and Tolerability of Topical 10% Terbinafine Hydrogen Chloride Versus 5% Amorolfine Nail Lacquer in Patients With Mild to Moderate Toenail Onychomycosis

PHASE3CompletedINTERVENTIONAL

Enrollment

1,029

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions

Onychomycosis

Interventions

DRUG

terbinafine hydrogen chloride

10 % terbinafine hydrogen chloride (HCL)

DRUG

amorolfine nail lacquer

5 % amorolfine nail lacquer

Trial Locations (10)

Unknown

Novartis Investigative Site, Various Cities

Novartis Investigative Site, Various Cities

Novartis Investigative Site, Various Cities

Novartis Investigative Site, Various Cities

Novartis Investigative Site, Various Cities

Novartis Investigative Site, Various Cities

Novartis Investigative Site, Various Cities

Novartis Investigative Site, Various Cities

Novartis Investigative Site, Various Cities

Novartis Investigative Site, Various Cities

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY

NCT00459537 - Efficacy, Safety and Tolerability of Topical 10% Terbinafine Hydrogen Chloride Versus 5% Amorolfine Nail Lacquer in Patients With Mild to Moderate Toenail Onychomycosis | Biotech Hunter | Biotech Hunter